Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 5
2005 3
2006 5
2007 6
2008 15
2009 17
2010 16
2011 32
2012 34
2013 34
2014 47
2015 50
2016 31
2017 21
2018 20
2019 23
2020 33
2021 55
2022 38
2023 20
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

469 results

Results by year

Filters applied: . Clear all
Page 1
Overcoming Endocrine Resistance in Breast Cancer.
Hanker AB, Sudhan DR, Arteaga CL. Hanker AB, et al. Cancer Cell. 2020 Apr 13;37(4):496-513. doi: 10.1016/j.ccell.2020.03.009. Cancer Cell. 2020. PMID: 32289273 Free PMC article. Review.
CD8+ T cell differentiation and dysfunction in cancer.
Philip M, Schietinger A. Philip M, et al. Nat Rev Immunol. 2022 Apr;22(4):209-223. doi: 10.1038/s41577-021-00574-3. Epub 2021 Jul 12. Nat Rev Immunol. 2022. PMID: 34253904 Free PMC article. Review.
Corticosteroids and Cancer Immunotherapy.
Goodman RS, Johnson DB, Balko JM. Goodman RS, et al. Clin Cancer Res. 2023 Jul 14;29(14):2580-2587. doi: 10.1158/1078-0432.CCR-22-3181. Clin Cancer Res. 2023. PMID: 36648402 Free PMC article. Review.
Immune-checkpoint inhibitors: long-term implications of toxicity.
Johnson DB, Nebhan CA, Moslehi JJ, Balko JM. Johnson DB, et al. Nat Rev Clin Oncol. 2022 Apr;19(4):254-267. doi: 10.1038/s41571-022-00600-w. Epub 2022 Jan 26. Nat Rev Clin Oncol. 2022. PMID: 35082367 Free PMC article. Review.
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander MR, Bloomer TL, Becker JR, Slosky DA, Phillips EJ, Pilkinton MA, Craig-Owens L, Kola N, Plautz G, Reshef DS, Deutsch JS, Deering RP, Olenchock BA, Lichtman AH, Roden DM, Seidman CE, Koralnik IJ, Seidman JG, Hoffman RD, Taube JM, Diaz LA Jr, Anders RA, Sosman JA, Moslehi JJ. Johnson DB, et al. N Engl J Med. 2016 Nov 3;375(18):1749-1755. doi: 10.1056/NEJMoa1609214. N Engl J Med. 2016. PMID: 27806233 Free PMC article.
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.
Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB. Hyman DM, et al. Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31. Nature. 2018. PMID: 29420467 Free PMC article. Clinical Trial.
469 results